Home/Pipeline/AMEND™ Annuloplasty Ring

AMEND™ Annuloplasty Ring

Mitral Regurgitation

Early FeasibilityActive

Key Facts

Indication

Mitral Regurgitation

Phase

Early Feasibility

Status

Active

Company

Innovative transcatheter mitral valve repair platform targeting minimally invasive treatment of mitral regurgitation.

Drug	Company	Phase	Status
MIA-M Percutaneous Annuloplasty System	Micro Interventional Devices	Pre-clinical	Active
AMEND™ Transseptal Delivery System	Valcare Medical	Early Feasibility	Active
GeminiOne TEER System	Peijia Medical	Pre-market (NMPA under review)	Clinical enrollment completed